Lasa Supergenerics (LASA) — concall transcript

📢 Key Event
LASA reported FY2021 revenue of Rs.20.37 crores, up 21% YoY, with EBITDA at Rs.47.28 crores and PAT at Rs.22.80 crores (11.3% margin), driven by export growth and backward integration.

🔄 What Changed
Revenue grew 21% YoY to Rs.20.37 crores; EBITDA grew 57% to Rs.47.28 crores; PAT surged 530% to Rs.22.80 crores; cash flow from operations rose to Rs.241 crores; export contribution remained ~40% of revenue.

🔮 What's Next
Target 20-25% CAGR in sales; launching two blockbuster products with ~Rs.2000 crores market size; quarterly dividends; capex funded via internal accruals; Harishree merger to close by June 12, 2021.

💡 Investor Takeaway
Strong cash flow and margin expansion support sustainable growth and shareholder returns, but regulatory and export dependency pose execution risks.

LASA reported FY2021 revenue of Rs.20.37 crores, up 21% YoY, with EBITDA at Rs.47.28 crores and PAT at Rs.22.80 crores (11.3% margin), driven by export growth and backward integration. Management highlighted strong cash flow (Rs.241 crores from operations), a 20-25% CAGR growth outlook, and plans for two blockbuster product launches. Expansion of Harishree unit will add regulatory approvals and capacity, with no new acquisitions planned. Key risks include vaccine procurement impact and regulatory hurdles for new products.

📄 View Original Announcement (PDF)

📊 Stock Analysis — LASA ✨ Ask AI About This

About Lasa Supergenerics Ltd (LASA)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹31.41 Cr ROE: -20.2% ROCE: -17.9%

View full LASA stock details →

📡 Get AI alerts when LASA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LASA — Free

💡 Ask AI about this filing

"What is the expected revenue contribution from the two blockbuster product launches?" "How will Harishree merger impact LASA's regulatory approvals and export capacity?" "What is the timeline for achieving the 20-25% CAGR growth target?"

Ask AI Free →

📊 More LASA filings

See all LASA filings →

🔥 Also filed on 31 March 2021

AYMSYNTEX AYM Syntex Ltd concall transcript SANDUMA Sandur Manganese & Iron Ores Ltd concall transcript SADBHAV Sadbhav Engineering Ltd concall transcript SADBHIN Sadbhav Infrastructure Projects Ltd concall transcript RKEC RKEC Projects Ltd concall transcript

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LASA files new disclosures

Track LASA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track LASA — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd